$15.050
+0.060 (+0.40%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MLTX Prediction & Forecast by Similar Chart Analysis
Alphio's MLTX stock price prediction model matches the current MoonLake Immunotherapeutics tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.04 (-0.05%). The 1-week path is $15.42 (+2.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy MoonLake Immunotherapeutics Stock?
MoonLake Immunotherapeutics is currently a hold. The stock is priced at $14.99, significantly below analyst price targets of $50 and $70, indicating potential upside. However, the RSI is at a low 22.34, suggesting oversold conditions but also a lack of momentum. The company reported a narrower loss of $0.84 per share against an expected loss of $0.93, which is a positive sign, yet the overall financial performance shows consistent losses, with a net income of -69,707,000 in Q1 2026. The main risk is the ongoing negative earnings trend, with a projected loss of -61,805,000 in Q2 2026.
MLTX stock price ended at $15.05 on Monday, after rising +0.40%
MoonLake Immunotherapeutics (MLTX) last closed at $15.05, gaining +0.40%. These facts feed the 1-day and 1-week MLTX price prediction above.
Forecast Drivers
MoonLake Immunotherapeutics (MLTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MLTX, ranked by similarity.
Seasonality analysis for MLTX
Historically the probability of a positive September return for MLTX is 34.15%. August offers the highest probability of a positive month at 53.12%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MLTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $59.68 | $64.11 | $69.26 | +325.95% |
| Oct 2026 | $43.26 | $52.83 | $62.28 | +251.00% |
| Nov 2026 | $55.25 | $64.11 | $67.12 | +325.95% |
| Dec 2026 | $46.62 | $47.38 | $48.66 | +214.84% |
In 2026, MoonLake Immunotherapeutics (MLTX) is projected to range from $43.26 to $69.26.
MoonLake Immunotherapeutics 2026 monthly forecast
In Sep 2026, MoonLake Immunotherapeutics is projected to average $64.11, with a low of $59.68 and high of $69.26.
In Oct 2026, MoonLake Immunotherapeutics is projected to average $52.83, with a low of $43.26 and high of $62.28.
In Nov 2026, MoonLake Immunotherapeutics is projected to average $64.11, with a low of $55.25 and high of $67.12.
In Dec 2026, MoonLake Immunotherapeutics is projected to average $47.38, with a low of $46.62 and high of $48.66.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.